← All stocks

Syndax Pharmaceuticals Inc

SNDX Net selling

CIK 0001395937 #2145 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.75M

$0.00 on a plan · $1.97M straight out of an exercise

Sold at will

$780.67K

6 of 9 sales

Net

−$2.75M

−$780.67K against sales at will

By person

11 insiders · 9 transactions

15.5×

Michael A. Metzger holds 15.5 times base salary in stock. $11.75M of shares against $754.30K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael A. Metzger last reported holding, valued at $24.24, the price Common Stock was last bought or sold at on the open market here, on 8 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Metzger Michael A

Chief Executive Officer

—

$1.43M (4) scheduled

−$1.43M

484,843

0.5430%

$11.75M

+195.8%

Botwood Nicholas A.J.

Head of R&D, CMO

—

$1.18M (2) scheduled

−$1.18M

60,885

0.0682%

$1.48M

+6,780%

Goldan Keith A.

Chief Financial Officer

—

$136.99K (3)

−$136.99K

139,252

0.1559%

$3.38M

+164.6%

Podlesak Dennis

Director

—

239,763

0.2685%

$5.81M

+69.1%

Katkin Keith

Director

—

124,000

0.1389%

$3.01M

+90.8%

Jarrett Jennifer

Director

—

114,000

0.1277%

$2.76M

+75.4%

Legault Pierre

Director

—

114,000

0.1277%

$2.76M

+75.4%

Huber Martin H. Jr.

Director

—

103,000

0.1153%

$2.50M

+110.2%

Meury William

Director

—

90,000

0.1008%

$2.18M

+38.5%

Gallagher Neil

President, Head of R&D

—

85,095

0.0953%

$2.06M

+78.0%

Rizo Aleksandra

Director

—

49,000

0.0549%

$1.19M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Metzger Michael A

8 Jul 2026

Chief Executive Officer

Sold after exercise

32,375

$24.24

$784.78K

Botwood Nicholas A.J.

12 Jun 2026

Head of R&D, CMO

Sold after exercise

31,235

$18.14

$566.60K

Botwood Nicholas A.J.

11 Jun 2026

Head of R&D, CMO

Sold after exercise

34,280

$18.00

$617.04K

Metzger Michael A

1 Jun 2026

Chief Executive Officer

Sell

6,847

$18.99

$130.02K

Goldan Keith A.

1 Jun 2026

Chief Financial Officer

Sell

1,177

$18.99

$22.35K

Goldan Keith A.

9 Feb 2026

Chief Financial Officer

Sell

3,410

$21.03

$71.71K

Metzger Michael A

9 Feb 2026

Chief Executive Officer

Sell

17,159

$21.03

$360.82K

Goldan Keith A.

6 Feb 2026

Chief Financial Officer

Sell

2,082

$20.62

$42.93K

Metzger Michael A

6 Feb 2026

Chief Executive Officer

Sell

7,412

$20.62

$152.84K

What was left out

Form 4 filings counted 16

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 3

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 586,418

History held since 2 Nov 2016